by Strados Labs | Nov 18, 2021 | Press Releases
CE Mark expands the company’s reach to support customers on a global scale Philadelphia, PA, November 18, 2021 – Strados Labs, a medical technology company harnessing the power of smart sensors to aid in early detection and predictions of worsening diseases for...
by Strados Labs | Dec 22, 2020 | Press Releases
Philadelphia, PA December 22, 2020 — Strados Labs, a health technology developer of remote respiratory devices and software, today announced it has received FDA Class II 510(k) clearance for its first product, RESP™, a system for measuring, recording and analyzing...
by Strados Labs | Aug 13, 2020 | Press Releases
Small Business Innovation Research Program Provides Seed Funding for R&D Philadelphia, PA, August 13, 2020 – Strados Labs has been awarded a National Science Foundation (NSF) Phase I Small Business Innovation Research (SBIR) grant for $224,470 to conduct research...
by Strados Labs | Mar 19, 2020 | Press Releases
As hospitals and ICUs begin to fill following the coronavirus outbreak, this remote monitoring platform could save lives, time, and money Philadelphia, PA, March 19, 2020 – An innovative remote respiratory device created by Strados Labs has the potential to save...
by Strados Labs | Aug 22, 2019 | Press Releases
Houston, TX and Philadelphia, PA, August 22, 2019 – An innovative program at Harris County Public Health is aiming to bring remote patient access to under-served Houston children suffering from asthma. Leading-edge technology from Strados Labs, the creator of the...
by Strados Labs | Feb 12, 2019 | Press Releases
Philadelphia, PA, February 12, 2019 — Strados Labs, creator of the world’s first remote respiratory monitoring platform, announced today the addition of three new executives to its management team. Strados Labs’ remote respiratory monitoring platform gives clinicians...